Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Access

Set Alert for Market Access

Exec Chat: Koa Accel Learns From Past Mistakes To Help Medtech Inventors (Part 2)

Koa Accel CEO Francis Duhay tells Medtech Insight what his company looks for when choosing medtech ideas to support and how his experience as a physician and inventor informs his investment strategy.

Business Strategies Exec Chat Financing

Latest From Market Access

Device Week, 8 November 2019 – Medicare Rules!

Some exciting changes to US Medicare payment rules will take effect in January for device-related procedures performed in different hospital settings. On this week’s podcast, executive editor Shawn M. Schmitt chats with senior reporter Sue Darcey, who covered these changes for Medtech Insight – as well news out of the Centers for Medicare and Medicaid Services (CMS) that it designated several new medical technologies for passthrough payments and will offer new home-use infusion therapy benefits.

Device Week Medicare

Final 2020 CMS Outpatient, ASC Payment Rules Broaden Patient Access To Medtech

The US Medicare agency is allowing more device procedures to be conducted at outpatient hospitals and ambulatory surgical centers (ASC), while approving several new devices for passthrough payments for three years under its Outpatient Prospective Payment System and ASC payment system final rule for 2020, released on 1 November.

Policy Medicare

UK IVDs Broach Brexit Preparedness In Case Of No-Deal EU Exit

With the current Brexit date less than a month away, the UK IVDs industry is busy providing support to UK manufacturers and the pathology sector in an attempt to ensure no one gets caught out. Coinciding with this are the ongoing preparations for the EU IVDR, and a raft of UK-specific issues for the diagnostics industry.          

United Kingdom Medical Device

Australia Reviews Ban On Many Self-Testing IVDs

A new public consultation is looking at whether Australia’s rules prohibiting the supply of many types of self-testing IVDs are still fit for purpose.

In Vitro Diagnostics Australia

Market Brief: Global Fracture Fixation Market To Hit $10.8Bn By 2023

The global market for fracture fixation products is expected to reach nearly $10.8bn by 2023, a CAGR of 5.9%. Internal fixation devices for small-bone fractures are expected to see the largest growth over the forecast period, according to a new analysis by Meddevicetracker.

Orthopedics Surgery

QUOTED. 29 August 2019. Tim Herbert.

Medicare administrative contractors for 19 US states have proposed supplying local Medicare coverage for hypoglossal nerve stimulation (HNS) provided by Inspire Medical Systems’ Inspire therapy to treat obstructive sleep apnea. See what company president and CEO Tim Herbert said about it here.

Quoted Medicare
See All
UsernamePublicRestriction

Register